000			01969nam a2200337 4500
001			5856
010			_a9291680877
090			_a5856
100			_a20010326d1999 y0pory50 ba
101			_aeng
200			_aReport on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs _fEuropean Monitoring Centre for Drugs and Drug Addiction
210			_aLuxembourg _cOffice for Official Publication of the European Communities _d1999
215			_a114 p. _cil. _d21 cm
225			_aImplemention of the joint action
300			_aInformação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https:/www.emcdda.org
330			_aReport on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Council decision of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties. Europol-EMCDDA progress report on 4-MTA in accordance with article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Review of the pharmacotoxicological data on 4-MTA. Public health risks of 4-MTA: epidemiological evidence. Sociological and criminological evidence on the risks of 4-MTA.
606			_aDROGAS ILÍCITAS _96631
606			_aSUBSTÂNCIAS PSICOTRÓPICAS _96333
606			_aCOOPERAÇÃO INTERNACIONAL _9581
606			_aSAÚDE PÚBLICA _91370
606			_aEUROPOL _9103050
606			_aCONSELHO DA EUROPA _96334
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA _95764
852			_jDRO319